Literature DB >> 29872476

Management of Type 2 Diabetes - Methods for Addition of Prandial to Basal Insulin.

W Rodbard Helena1, Boris Karolicki2.   

Abstract

As glycaemic control deteriorates with the progression of type 2 diabetes, treatment guidelines advocate starting basal insulin therapy, and then progressing to a basal-bolus regimen as needed. Nevertheless, although timely intensification of therapy is important to minimise the risk of diabetic complications, considerable clinical inertia exists, not only in the initiation of insulin but also in the progression to multiple-dose insulin regimens. One barrier has been the lack of guidance about how to make the transition from basal-only to basal-bolus insulin therapy. In this review, we discuss how data from the recent FullSTEP study, along with other randomised studies, will help to bridge this gap. Prandial boluses can be added to basal insulin in a stepwise manner, using a straightforward, patient-led dose titration approach and simple estimation of which meal to add the initial prandial bolus to. Reducing the complexity of progression to multiple-dose insulin regimens and empowering patients will lessen the burden on clinicians, improve treatment satisfaction and facilitate timely implementation of treatment guidelines.

Entities:  

Keywords:  Type 2 diabetes; basal-bolus; insulin; patient satisfaction; self-titration; stepwise; treatment intensification

Year:  2014        PMID: 29872476      PMCID: PMC5983081          DOI: 10.17925/EE.2014.10.02.124

Source DB:  PubMed          Journal:  Eur Endocrinol        ISSN: 1758-3772


  52 in total

Review 1.  Metabolic control and risk of hypoglycaemia during the first year of intensive insulin treatment in type 2 diabetes: systematic review and meta-analysis.

Authors:  A E Pontiroli; L Miele; A Morabito
Journal:  Diabetes Obes Metab       Date:  2012-01-17       Impact factor: 6.577

2.  The loss of postprandial glycemic control precedes stepwise deterioration of fasting with worsening diabetes.

Authors:  Louis Monnier; Claude Colette; Gareth J Dunseath; David R Owens
Journal:  Diabetes Care       Date:  2007-02       Impact factor: 19.112

3.  Diagnosis and classification of diabetes mellitus.

Authors: 
Journal:  Diabetes Care       Date:  2014-01       Impact factor: 19.112

Review 4.  Basal plus basal-bolus approach in type 2 diabetes.

Authors:  F Javier Ampudia-Blasco; Paolo Rossetti; Juan F Ascaso
Journal:  Diabetes Technol Ther       Date:  2011-06       Impact factor: 6.118

5.  Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients.

Authors:  M Shichiri; H Kishikawa; Y Ohkubo; N Wake
Journal:  Diabetes Care       Date:  2000-04       Impact factor: 19.112

Review 6.  Self-titration of insulin in the management of people with type 2 diabetes: a practical solution to improve management in primary care.

Authors:  K Khunti; M J Davies; S Kalra
Journal:  Diabetes Obes Metab       Date:  2013-01-29       Impact factor: 6.577

7.  AUTONOMY: the first randomized trial comparing two patient-driven approaches to initiate and titrate prandial insulin lispro in type 2 diabetes.

Authors:  Steve V Edelman; Rong Liu; Jennal Johnson; Leonard C Glass
Journal:  Diabetes Care       Date:  2014-04-17       Impact factor: 19.112

8.  Three-year efficacy of complex insulin regimens in type 2 diabetes.

Authors:  Rury R Holman; Andrew J Farmer; Melanie J Davies; Jonathan C Levy; Julie L Darbyshire; Joanne F Keenan; Sanjoy K Paul
Journal:  N Engl J Med       Date:  2009-10-22       Impact factor: 91.245

Review 9.  Do data in the literature indicate that glycaemic variability is a clinical problem? Glycaemic variability and vascular complications of diabetes.

Authors:  F Cavalot
Journal:  Diabetes Obes Metab       Date:  2013-09       Impact factor: 6.577

Review 10.  Clinical evidence for the earlier initiation of insulin therapy in type 2 diabetes.

Authors:  David R Owens
Journal:  Diabetes Technol Ther       Date:  2013-06-20       Impact factor: 6.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.